Pfizer beats Q1 forecast despite 20% revenue drop, cuts four pipeline programs

Pfizer announced its first-quarter 2024 earnings on Wednesday, reporting a 20% year-over-year decline in revenue attributable to the steep drop in demand for its COVID-19 products.